Osteoradionecrosis

Osteoradionecrosis (ORN) of the jaws is a severe late complication of head and neck radiation therapy (RT), defined as non-healing bone within a previously irradiated field, persisting for at least 3 months in the absence of recurrent or residual neoplasm.[1][2] The condition results from radiation-induced damage to bone and its supporting vasculature and soft tissues. Two complementary pathogenic theories predominate: the hypoxic-hypocellular-hypovascular ("3H") model, in which radiation-induced endarteritis and cellular death create a compromised tissue environment; and the radiation-induced fibroatrophic model, in which dysregulated fibroblast-to-myofibroblast transformation produces an abnormal extracellular matrix with progressive loss of osteoblastic repopulation and eventual necrosis.[3][4] The mandible is affected far more often than the maxilla owing to its relatively poor vascular supply, dense cortical bone, and high radiation absorption.[5] Radiographically, ORN characteristically presents as a lytic or mixed lytic-sclerotic lesion of bone.[2] Management ranges from conservative measures and medical therapy to segmental resection with microvascular reconstruction, depending on disease severity.[5][6]

The ISOO-MASCC-ASCO guideline (2024) endorses the operational term osteoradionecrosis of the jaw and recommends the ClinRad classification system for standardized characterization and staging.[2] More than 9 published definitions and at least 16 classification systems have been described, contributing to reporting ambiguity.[7] Historically, the Notani classification (Stages I–III, based on anatomic extent and complications) has been widely used in clinical trials.[8][9] The term "radiation osteitis" has occasionally appeared in older literature but is not currently recommended. ORN must be distinguished from medication-related osteonecrosis of the jaw (MRONJ), which shares overlapping clinical and radiographic features but arises in the context of antiresorptive or antiangiogenic therapy rather than radiation.[3][10]

• Incidence: Prevalence estimates range from 2% to 15%, with most contemporary series reporting approximately 3–8% in patients treated with curative-intent RT. In a large cohort of 6,199 patients, the overall incidence was 4.5%.[11][12][13]
• Radiation modality: IMRT/VMAT has reduced ORN risk compared with conventional 2D/3D techniques, particularly in nasopharyngeal carcinoma. Proton therapy may further lower risk, though higher rates have also been reported in some series.[3][13]
• Dose threshold: Radiation doses ≥60 Gy to the jaw are associated with the highest risk; the ISOO-MASCC-ASCO guideline considers ≥50 Gy a risk threshold. A dose-volume analysis identified D10cc of approximately 59 Gy as the most discriminative parameter.[2][14][15]
• Latency: Median onset is approximately 13–27 months post-RT, with a wide range (2–122 months); the risk does not diminish over time.[1][16][17]
• Site: The mandible is involved in the majority of cases, with the posterior body and angle most commonly affected. Maxillary ORN is less common and has been historically underrecognized. Oral cavity and oropharyngeal primary tumors carry the highest site-specific risk.[5][12][13][17]
• Risk factors: Post-RT dental extraction (strongest precipitant), smoking, alcohol use, poor periodontal status (stage III–IV), advanced tumor stage, and abnormal body mass index.[12][13][14]

ORN presents along a clinical spectrum from asymptomatic radiographic findings to severe functional impairment.[1][3]

Presentation and symptoms

• Exposed bone: The hallmark finding is exposed, devitalized bone visible through mucosal breakdown or probeable through a fistula or periodontal pocket. The exposed bone typically appears rough, yellowish-white, and non-vital.[2][3]
• Pain: Common and often progressive; may include deep, dull bone pain, odontalgia, or referred pain.[3][17]
• Infection: Secondary bacterial infection is frequent, manifesting as erythema, swelling, purulent discharge, and malodor.[3][5]
• Fistulae: Intraoral or extraoral (cutaneous) fistulae develop in advanced disease and are significantly more common in ORN than in MRONJ.[5][10]

Complications and red flags

• Pathologic fracture: Occurs in advanced disease when necrosis extends through the full thickness of the mandible, particularly below the level of the inferior alveolar canal.[5][8]
• Trismus: Progressive limitation of mouth opening due to fibrosis of masticatory muscles and/or direct involvement of the temporomandibular region.[5][18]
• Neurologic changes: Paresthesia or anesthesia of the inferior alveolar nerve distribution; new neurologic symptoms should raise concern for tumor recurrence.[3][18]
• Functional impairment: Dysphagia, masticatory dysfunction, and speech difficulty may accompany advanced ORN.[1]

Tempo

ORN may develop spontaneously or be precipitated by dental extraction, denture trauma, or periodontal disease.[16] The clinical course is typically chronic and progressive, though some early lesions may stabilize or resolve with conservative management.[19]

The ISOO-MASCC-ASCO guideline operationally characterizes ORN as a "radiographic lytic or mixed sclerotic lesion of bone" within a previously irradiated field.[2] Radiographic findings may be absent in early disease and can lag behind clinical progression; conversely, radiographic ORN may be present with clinically intact mucosa.[19][20] Panoramic radiography is sensitive primarily for advanced involvement, as mineral loss must reach approximately 30–50% before becoming visible on two-dimensional images.[21]

Location and distribution

• The posterior mandibular body and angle are the most commonly affected sites, corresponding to the region of highest radiation dose and poorest vascular supply.[5][19]
• Mandibular involvement predominates; maxillary ORN is uncommon.[12][17]
• Lesions typically arise within the highest-dose radiation field, most often ipsilateral to the primary tumor.[19]
• Focal bone alterations are more frequent than diffuse involvement.[17]

Periphery and shape

• Margins are characteristically ill-defined and irregular, without a corticated border.[22]
• The lesion lacks the well-demarcated periphery seen in cystic or benign neoplastic processes.
• Cortical disruption with ragged, moth-eaten margins is common, particularly along the buccal cortex.[22][23]

Internal architecture

• Early changes: Loss of alveolar bone density, widening of the periodontal ligament space, and subtle trabecular rarefaction. These findings may precede clinical bone exposure.[3][24]
• Established disease: Progressive osteolysis with loss of normal trabecular pattern, often producing a mottled or moth-eaten radiolucent appearance. Necrotic islands of bone (sequestra) appear as radiopaque fragments surrounded by radiolucency.[3][17]
• Mixed pattern: Although predominantly lytic, ORN commonly demonstrates mixed lytic and sclerotic changes; sclerosis is a characteristic feature and was present in the majority of cases in CT-based studies. Sclerosis likely represents a reactive bone response to radiation injury.[17][18][25]
• Progression: A predictable radiological sequence has been described, beginning with trabecular resorption and cortical erosion, advancing to fragmentation and sequestrum formation.[17]

Effects on teeth and adjacent structures

• Widening of the periodontal ligament space is an early radiographic sign, reflecting the devitalized condition of irradiated bone.[3][24]
• Thickening of the lamina dura is characteristically absent in ORN, in contrast to MRONJ and osteomyelitis where it may be prominent.[21]
• Teeth within the affected zone may show loss of supporting alveolar bone, mobility, and eventual exfoliation.
• Soft-tissue changes adjacent to osseous ORN—including mass-like thickening and enhancement of the masticator muscles—can be prominent and should not be mistaken for tumor recurrence.[23]

Extent and cortical involvement

• Cortical bone resorption is a characteristic finding, significantly more prevalent in ORN than in osteomyelitis on both panoramic and cross-sectional imaging.[21]
• The ClinRad classification grades severity by the vertical extent of bone necrosis: disease confined to the alveolar process versus extension to the basal bone, with or without exposed bone or fistula.[2][12]
• The Notani system similarly stratifies by anatomic depth: Stage I (alveolar bone only), Stage II (above the mandibular canal), and Stage III (below the canal, or with skin fistula or pathologic fracture).[8]
• Full-thickness mandibular involvement with pathologic fracture represents the most advanced stage.[5][8]

Recognized variants and imaging pitfalls

• Radiographic-only ORN (Grade 0): Lytic or mixed lesion identified on imaging with clinically intact overlying mucosa; increasingly recognized as a valid early presentation.[19]
• Panoramic radiography limitations: Two-dimensional imaging has limited sensitivity for early disease and limited ability to differentiate ORN from other osteonecrotic conditions; cross-sectional imaging (CBCT) achieves a higher predictive value for pathological status.[21]
• Overlap with tumor recurrence: ORN and recurrent malignancy can produce similar patterns of bone destruction. Bony sclerosis is significantly more prevalent in ORN and was not observed with tumor recurrence in one comparative study, whereas a discrete solid or cystic soft-tissue mass strongly favors recurrence.[25]

Medical CT

CT demonstrates cortical disruption, trabecular disorganization, fragmentation, and sequestrum formation with high sensitivity.[17][23] Bony sclerosis on CT is a distinguishing feature of ORN compared with tumor recurrence, where sclerosis is characteristically absent.[25] Paired CT and panoramic imaging significantly improves diagnostic accuracy across specialties compared with either modality alone.[26]

MRI

MRI of mandibular ORN shows homogeneous T1 hypointensity, T2 hyperintensity, and intense enhancement of the bone marrow in the involved segment.[23][27] Adjacent masticator muscles may demonstrate abnormal T2 hyperintensity and diffuse enhancement that can appear mass-like but does not represent tumor recurrence.[23] MRI is particularly useful for differentiating ORN from malignancy and for confirming the presence of osteomyelitis.[3] Early radiation-induced marrow changes—T1 hypointensity, T2 hyperintensity, and post-gadolinium enhancement—may precede overt necrosis.[27]

PET/CT and nuclear medicine

¹⁸F-FDG PET/CT has limited specificity for ORN, as both ORN and tumor recurrence demonstrate increased uptake with significant overlap in SUV values.[3][25] Bone scintigraphy (⁹⁹ᵐTc) similarly reflects inflammation rather than necrosis specifically and is of limited diagnostic value.[3]

ORN must be distinguished from other conditions that produce bone destruction or exposed bone in the jaws of patients with a history of head and neck cancer treatment. Clinical history—particularly radiation dose to the affected site, medication exposure, and absence of recurrent tumor—is essential for accurate diagnosis.[2][28]

The highest-risk diagnostic pitfall is misidentifying tumor recurrence as ORN (or vice versa), as both produce bone destruction in the irradiated field. New neurologic symptoms, a discrete soft-tissue mass, or progressive destruction despite ORN management should prompt biopsy to exclude malignancy.[18][25]

Histopathologic examination of ORN specimens reveals a distinctive pattern, though microscopic findings alone cannot reliably differentiate ORN from other forms of jaw osteonecrosis.[29]

Characteristic microscopic findings

• Necrotic bone: Non-vital lamellar bone with empty osteocytic lacunae and devitalized Haversian and Volkmann canals—a feature shared with other osteonecrotic conditions.[3][30]
• Marrow changes: The marrow space is characteristically replaced by collagenous, hypocellular, and hypovascular fibrous tissue, distinguishing ORN from suppurative osteomyelitis (which shows intense marrow inflammation) and MRONJ (which shows empty marrow with absent osteoclasts).[30]
• Periosteum: Non-viable periosteum is a hallmark of ORN, in contrast to both osteomyelitis and MRONJ where periosteal viability is typically preserved.[30]
• Osteoclasts: Osteoclasts are scarce to absent in ORN specimens, though recent evidence suggests paradoxical osteoclast activation may contribute to disease progression.[29][31]
• Vascular changes: Hyperemia, endarteritis, and thrombosis of marrow vessels are observed, with progressive hypovascularity and fibrosis.[32]
• Bacterial colonization: Variable surface bacterial colonization is common, with Actinomyces colonies less prevalent in ORN than in MRONJ.[3][33]

Radiologic-pathologic correlation

The histopathologic sequence—from initial vascular injury and cellular loss to fibrosis and eventual necrosis—correlates with the radiographic progression from subtle trabecular rarefaction to osteolysis, fragmentation, and sequestrum formation.[17][32] Cortical bone, particularly near the inferior mandibular border, tends to show more extensive necrotic changes than cancellous bone, which may retain viability even adjacent to areas of advanced destruction.[34] This heterogeneity has implications for surgical planning, as debridement to a "bleeding edge" may not ensure viable cortical margins.[34]

Classification-guided approach

The ISOO-MASCC-ASCO guideline recommends the ClinRad classification system for standardized staging and treatment planning.[2] The ClinRad system grades ORN by the vertical extent of radiographic bone necrosis and the presence or absence of exposed bone or fistula, and statistically outperformed 15 prior systems in predicting serious ORN events (pathologic fracture or need for jaw resection).[12]

Prevention

• Pre-RT dental evaluation with extraction of teeth with poor prognosis at least 2 weeks before RT initiation.[35]
• Long-term preventive protocols including daily high-potency topical fluoride, meticulous oral hygiene, xerostomia management, and regular dental recall.[35]
• Consultation with the radiation oncology team before any future extractions or surgery in the irradiated field.[35]

Conservative and medical management

• Early/stable disease: Close monitoring, strict oral hygiene, chlorhexidine rinses, and systemic antibiotics for active infection.[19][35]
• Pentoxifylline and tocopherol (PENTO): Pentoxifylline 400 mg twice daily and tocopherol (vitamin E) 1000 IU daily target the fibroatrophic mechanism. In a phase II trial, prolonged PENTOCLO therapy (adding clodronate 1600 mg daily) achieved complete mucosal and bone healing in all 54 patients with refractory mandibular ORN at a median of 9 months. A randomized controlled trial (RAPTOR) is underway to provide definitive evidence. The PENTO protocol may reduce the need for major surgical intervention.[36][37][38][39]
• Hyperbaric oxygen (HBO): The role of HBO remains controversial; recent guidelines and reviews have found insufficient evidence to support routine use for prevention or management of ORN.[16][19]

Surgical management

• Sequestrectomy/debridement: Appropriate for limited disease with mobile sequestra; provides symptom relief but achieves long-term healing in only a minority of cases.[6][19]
• Segmental resection with microvascular reconstruction: Required for advanced ORN with pathologic fracture, cutaneous fistulae, or full-thickness bone involvement. Segmental mandibulectomy is significantly more effective than debridement in achieving healed ORN (OR 10.7). Free osteocutaneous flaps (e.g., fibula) are the standard reconstructive approach.[5][6]

Prognosis

ORN carries substantial morbidity and mortality; in one surgical cohort, 19% of patients died during follow-up.[6] The risk of ORN is lifelong and does not diminish over time after RT.[1] Early recognition and interprofessional management involving dental specialists, radiation oncologists, and head and neck surgeons are essential for optimizing outcomes.[2][40]